Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hair loss can be an early sign of prostate enlargement.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Method quickly measures finasteride concentration in capsules.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Suppressing certain hormones might help prevent prostate cancer.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Certain drugs that block specific enzymes can help treat prostate diseases.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.